RESUMO
FUNDAMENTO: A necessidade de melhorar a acurácia do teste de esforço, determinou o desenvolvimento de escores, cuja aplicabilidade já foi amplamente reconhecida. OBJETIVO: Avaliação prognóstica do coronariopata estável através de um novo escore simplificado. MÉTODOS: Um novo escore foi aplicado em 372 coronariopatas multiarteriais e função ventricular preservada, 71,8 por cento homens, idade média 59,5 (± 9,07) anos, randomizados para angioplastia, revascularização cirúrgica e tratamento clínico, acompanhados por 5 anos. Óbito cardiovascular foi o desfecho primário. Infarto do miocárdio não-fatal, óbito e re-intervenção formaram o desfecho combinado secundário. O escore baseou-se numa equação previamente validada resultante da soma de 1 ponto para: sexo masculino, história de infarto, angina, diabete, uso de insulina e ainda 1 ponto para cada década de vida a partir dos 40 anos. Teste positivo adicionou 1 ponto. RESULTADOS: Ocorreram 36 óbitos (10 no grupo angioplastia, 15 no grupo revascularização e 11 no grupo clínico), p = 0,61. Observou-se 93 eventos combinados: 37 no grupo angioplastia, 23 no grupo revascularização e 33 no grupo clínico (p = 0,058). 247 pacientes apresentaram escore clínico > 5 pontos e 216 > 6 pontos. O valor de corte > 5 ou > 6 pontos identificou maior risco, com p = 0,015 e p = 0,012, respectivamente. A curva de sobrevida mostrou uma incidência de óbito após a randomização diferente naqueles com escore > 6 pontos (p = 0,07), e uma incidência de eventos combinados diferente entre pacientes com escore < 6 e > 6 pontos (p = 0,02). CONCLUSÃO: O novo escore demonstrou consistência na avaliação prognóstica do coronariopata estável multiarterial.
BACKGROUND: The need to improve the exercise testing accuracy, pushed the development of scores, whose applicability was already broadly recognized. OBJECTIVE: Prognostic evaluation of stable coronary disease through a new simplified score. METHODS: A new score was applied in 372 multivessel coronary patients with preserved ventricular function, 71.8 percent male, age: 59.5 (± 9.07) years old, randomized to medical treatment, surgery (CABG) or angioplasty (PTCA), with 5 years of follow-up. Cardiovascular death was considered the primary endpoint. Non-fatal myocardial infarction, death and re-intervention were considered for a combined secondary endpoint. The score was based on an equation previously validated, resulting from a sum of one point for: male gender, infarction history, angina, diabetes, insulin use and one point for each decade of life after 40 years old. Positive exercise testing summed one additional point. RESULTS: Thirty six deaths was observed (10 in group PTCA, 15 in CABG and 11 in the clinical group), p = 0.61. We observed 93 combined events: 37 in PTCA group, 23 in CABG and 33 in the clinical group (p = 0.058). 247 patients presented clinical score > 5 points and 216 > 6 points. The cutoff point > 5 or > 6 points identified higher risk, p = 0.015 and p = 0.012, respectively. The survival curve showed a different death incidence after the randomization when score reached 06 points or more (p = 0.07), and a distinct incidence of combined events between the patients with score < 6 and > 6 points (p = 0.02). CONCLUSION: The new score was consistent for multiarterial stable coronary disease risk stratification.
FUNDAMENTO: La necesidad de mejorar la exactitud de las pruebas de estrés, determinó el desarrollo de los puntajes, cuya aplicación fue ampliamente reconocida. OBJETIVO: La evaluación pronóstica del coronariópata estable a través de un nuevo score simplificado. MÉTODOS: Un nuevo score se aplicó en 372 coronariópatas multiarteriales y función ventricular preservada, el 71,8 por ciento varones, edad media de 59,5 (± 9,07) años, randomizados para angioplastia, revascularización quirúrgica y tratamiento clínico, seguidos de cinco años. Muerte cardiovascular fue el resultado primario. El infarto de miocardio no fatal, la muerte y la re-intervención formaron el desenlace combinado secundario. El score se basó en una ecuación previamente validada resultante de la suma de 1 punto a: sexo masculino, antecedentes de infarto, angina, diabetes, uso de insulina y todavía un punto por cada década de vida después de 40 años. Prueba positiva añadida 1 punto. RESULTADOS: Hubo 36 muertes (10 en el grupo de angioplastia, 15 en el grupo de revascularización y 11 en el grupo clínico), p = 0,61. Se observó 93 eventos combinados: 37 en el grupo angioplastia, 23 en el grupo revascularización y 33 en el grupo clínico (p = 0,058). Presentaron score clínico > 5 puntos y 216 > 6 puntos 247 pacientes. El valor de corte > 5 o > 6 puntos identificó un mayor riesgo, con p = 0,015 y p = 0,012, respectivamente. La curva de sobrevida mostró una incidencia de muerte después de la aleatorización que aquellos con score > 6 puntos (p = 0,07), y una incidencia de eventos combinados diferentes entre los pacientes con score < 6 y > 6 puntos (p = 0,02). CONCLUSIÓN: El nuevo score demostró consistencia en la evaluación pronóstica del coronariópata estable multiarterial. (Arq Bras Cardiol 2011;96(5):411-419).
Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Angina Pectoris , Doença das Coronárias , Teste de Esforço/métodos , Infarto do Miocárdio , Fatores Etários , Angina Pectoris/epidemiologia , Angioplastia Coronária com Balão/mortalidade , Angioplastia Coronária com Balão , Ponte de Artéria Coronária/mortalidade , Ponte de Artéria Coronária , Doença das Coronárias/mortalidade , Diabetes Mellitus/tratamento farmacológico , Métodos Epidemiológicos , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Infarto do Miocárdio/epidemiologia , Infarto do Miocárdio/mortalidade , Prognóstico , Fatores de TempoRESUMO
Several publications considering anatomical, histological, pathological, electrocardiographic, vectorcardiographic, and electrophysiologic studies have shown that the left bundle branch splits into three fascicles or in a "fan-like interconnected network" in the vast majority of human hearts. The left His system is trifascicular with a left anterior, a left posterior, and a left septal fascicle (LSF). Consequently, the classic term "hemiblock," to describe the block of one of the fascicles, established several decades ago by the Rosembaum's school, should be updated. Electrovectorcardiographic changes resulting from conduction abnormalities of the left anterior and left posterior fascicles are commonly diagnosed, mainly by their changes in the frontal plane. However, the existence of conduction defects of the LSF remains controversial. The ECG/VCG hallmark of LSF block is prominent anterior QRS forces (PAF) on the horizontal plane. This ECG/VCG phenomena should be distinguished from other conditions that also produce anterior QRS shift in the HP as: normal variants, right ventricular enlargement, misplaced precordial leads, lateral myocardial infarction, right bundle branch block, Wolff-Parkinson-White, obstructive and nonobstructive forms of hypertrophic cardiomyopahty, diastolic left ventricular enlargement, endomiocardial fibrosis, Duchenne muscular dystrophy, and dextroposition. The two highly frequent etiologies of LSFB are ischemia (coronary artery disease (CAD) with critical proximal obstruction of the left anterior descending coronary artery) and, in Latin America, Chagas' cardiomyopathy. The aims of this review are to revise the evidence of the existence of a trifascicular left Hissian system and to help in the ECG/VCG recognition of the LSFB.
Assuntos
Fascículo Atrioventricular/fisiopatologia , Bloqueio de Ramo/diagnóstico , Bloqueio de Ramo/fisiopatologia , Sistema de Condução Cardíaco/fisiopatologia , Vetorcardiografia/métodos , Bloqueio de Ramo/etiologia , HumanosRESUMO
BACKGROUND: The need to improve the exercise testing accuracy, pushed the development of scores, whose applicability was already broadly recognized. OBJECTIVE: Prognostic evaluation of stable coronary disease through a new simplified score. METHODS: A new score was applied in 372 multivessel coronary patients with preserved ventricular function, 71.8% male, age: 59.5 (± 9.07) years old, randomized to medical treatment, surgery (CABG) or angioplasty (PTCA), with 5 years of follow-up. Cardiovascular death was considered the primary endpoint. Non-fatal myocardial infarction, death and re-intervention were considered for a combined secondary endpoint. The score was based on an equation previously validated, resulting from a sum of one point for: male gender, infarction history, angina, diabetes, insulin use and one point for each decade of life after 40 years old. Positive exercise testing summed one additional point. RESULTS: Thirty six deaths was observed (10 in group PTCA, 15 in CABG and 11 in the clinical group), p = 0.61. We observed 93 combined events: 37 in PTCA group, 23 in CABG and 33 in the clinical group (p = 0.058). 247 patients presented clinical score ≥ 5 points and 216 ≥ 6 points. The cutoff point ≥ 5 or ≥ 6 points identified higher risk, p = 0.015 and p = 0.012, respectively. The survival curve showed a different death incidence after the randomization when score reached 06 points or more (p = 0.07), and a distinct incidence of combined events between the patients with score < 6 and ≥ 6 points (p = 0.02). CONCLUSION: The new score was consistent for multiarterial stable coronary disease risk stratification.
Assuntos
Angina Pectoris , Doença das Coronárias , Teste de Esforço/métodos , Infarto do Miocárdio , Fatores Etários , Angina Pectoris/epidemiologia , Angioplastia Coronária com Balão/mortalidade , Angioplastia Coronária com Balão/estatística & dados numéricos , Ponte de Artéria Coronária/mortalidade , Ponte de Artéria Coronária/estatística & dados numéricos , Doença das Coronárias/mortalidade , Diabetes Mellitus/tratamento farmacológico , Métodos Epidemiológicos , Feminino , Humanos , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/epidemiologia , Infarto do Miocárdio/mortalidade , Prognóstico , Fatores de TempoAssuntos
Bloqueio Atrioventricular/diagnóstico , Síndrome de Brugada/diagnóstico , Bloqueio de Ramo/diagnóstico , Erros de Diagnóstico/prevenção & controle , Anomalia de Ebstein/complicações , Eletrocardiografia , Sistema de Condução Cardíaco/fisiopatologia , Bloqueio Atrioventricular/etiologia , Bloqueio Atrioventricular/fisiopatologia , Síndrome de Brugada/fisiopatologia , Bloqueio de Ramo/etiologia , Bloqueio de Ramo/fisiopatologia , Anomalia de Ebstein/fisiopatologia , Feminino , Humanos , Adulto JovemAssuntos
Humanos , Masculino , Pessoa de Meia-Idade , Dor no Peito/complicações , Insuficiência Cardíaca/patologia , Paresia/complicações , Convulsões/complicações , Angiografia Coronária , Diagnóstico Diferencial , Reações Falso-Negativas , Evolução Fatal , Insuficiência Cardíaca/etiologia , Miocardite/diagnósticoRESUMO
Class III drugs prolong the QT interval by blocking mainly the delayed rectifier rapid potassium outward current (IKr), with little effect on depolarization. This K(+) channel in encoded by the human ether-a-go-go-related gene (hERG). Inhibition of hERG potassium currents by class III antiarrhythmic drugs causes lengthening of cardiac action potential, which produces a beneficial antiarrhythmic effect. Excessive prolongation of the action potential may lead to acquired long QT syndrome, which is associated with a risk of "torsade de pointes". Class III agents can block all types of potassium channels: IKs, IKr, IKur and IK1. The main representing class III agent is amiodarone. It is the gold standard in the prevention of recurrence of atrial fibrillation. Although it is highly effective in treating many arrhythmias, large number of adverse effects limits its clinical use. Dronedarone is a synthetic amiodarone analogue, iodine-free compound, with fewer adverse effects, and shares amiodarone's multichannel blocking effects, inhibiting transmembrane Na+, IKs, IKur, IK1, and slow Ca(++)L-type calcium currents. The main new generation class III drugs are: dofetilide, dronedarone, azimilide, and ibutilide. Oral dofetilide did not increase mortality in patients with a recent myocardial infarction or congestive heart failure. It is an alternative for the pharmacological conversion of atrial fibrillation and flutter. Azimilide blocks both rapid and slow potassium channels components. Azimilide is not a methanesulfonanilide compound. Trecitilide, tedisamil, ersentilide, ambasilide, chromanol and sematilide are class III miscellaneous agents. Old mixed agents are sotalol and bretylium. The present article reviews the main trials accomplished with these drugs.
Assuntos
Potenciais de Ação/efeitos dos fármacos , Amiodarona/farmacologia , Antiarrítmicos/farmacologia , Síndrome do QT Longo/induzido quimicamente , Amiodarona/uso terapêutico , Antiarrítmicos/uso terapêutico , Fibrilação Atrial/tratamento farmacológico , HumanosRESUMO
There are several papers in literature that prove in a conclusive and incontestable way, that the left branch of the His bundle, in most instances (85% of the cases) splits into three fascicles of variable morphological pattern, and not into two: left anterior fascicle (LAF), left posterior fascicle (LPF), and left septal fascicle (LSF). The abovementioned papers have anatomical, histological, anatomo-pathological, electrocardiographic, and vectocardiographic, body surface potential mapping or ECG potential mapping and electrophysiological foundation.Additionally, the mentioned papers have been performed both in animal models (dogs) and in the human heart.Several clinical papers have shown that the left septal fascicular block (LSFB) may occur intermittently or transitorily as a consequence of a temporary dromotropic alteration, constituting an aberrant ventricular conduction, rate-dependent or by the application of atrial extra-stimuli, or naturally during the acute phase of infarction when this involves the anterior descending artery, before the septal perforating artery that supplies the central portion of the septum, where the mentioned LSF runs.The ECG/VCG manifestation of LSFB consists in anterior shift of electromotive forces, known as Prominent Anterior Forces (PAF), which can hardly be diagnosed in the clinical absence of other causes capable of causing PAF, such as the normal variant by counterclockwise rotation of the heart on its longitudinal axis, in right ventricular enlargement, in the dorsal or lateral infarction of the new nomenclature, in type-A WPW, in CRBBB, and others. In this historical manuscript, we review in a sequential fashion, the main findings that confirmed the unequivocal existence of this unjustifiably "forgotten" dromotropic disorder.In the developed countries, its most important cause is coronary insufficiency, particularly the proximal involvement of the left anterior descending coronary artery, and in Latin America, Chagas disease.
Assuntos
Dor no Peito/complicações , Insuficiência Cardíaca/patologia , Paresia/complicações , Convulsões/complicações , Angiografia Coronária , Diagnóstico Diferencial , Reações Falso-Negativas , Evolução Fatal , Insuficiência Cardíaca/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Miocardite/diagnósticoRESUMO
OBJETIVO: Analisar os parâmetros do eletrocardiograma de alta resolução da onda P no domínio do tempo (ECGAR-P) e compará-los com: a duração da onda P no eletrocardiograma clássico (P no ECG), o diâmetro atrial esquerdo (AE) e a fração de ejeção do ventrículo esquerdo (FE) obtidos no ecocardiograma, para avaliar pacientes com fibrilação atrial paroxística (FAP). MÉTODOS: Foram estudados 181 pacientes: 117 com FAP comprovada e 64 sem FAP. Os parâmetros do ECGAR-P foram: a duração da onda P filtrada (DPF), as voltagens da raiz quadrada média dos últimos 40, 30 e 20 ms da onda P filtrada (RMS 40, RMS 30 e RMS 20), a voltagem da raiz quadrada média dos potenciais da onda P filtrada (RMS P), a integral dos potenciais da onda P filtrada (Integral P) e a duração dos potenciais tardios da onda P filtrada abaixo de 3 æV (PT<3). RESULTADOS: Os parâmetros que apresentaram diferenças estatisticamente significantes entre os grupos foram: DPF, RMS 40, 30 e 20, PT<3, P no ECG e AE. Os cálculos pela curva ROC mostraram, para cada parâmetro, o melhor valor de corte e os estimadores de desempenho: sensibilidade, especificidade, área sob a curva e p-value (p) ou nível descritivo. CONCLUSÃO: O ECGAR-P no domínio do tempo mostrou-se melhor que o eletrocardiograma clássico e o ecocardiograma para identificar pacientes com fibrilação atrial paroxística.
OBJECTIVE: To analyze the parameters of the time domain P-wave signal-averaged electrocardiogram (P-SAECG) and compare them with the P-wave duration on the conventional electrocardiogram (P on ECG) as well as the left atrium diameter (LAD) and left ventricular ejection fraction (EF) obtained on the echocardiogram in order to evaluate patients with paroxysmal atrial fibrillation (PAF). METHODS: One hundred and eighty-one patients were included in the study: 117 with confirmed PAF and 64 without PAF. The P-SAECG parameters used were: the filtered P-wave duration (FPD), the root mean square (RMS) voltages in the last 40, 30 and 20 ms of the filtered P-wave (RMS 40, RMS 30 and RMS 20), the root mean square voltage of the filtered P-wave potentials (RMS P), the integral of the potentials during the filtered P-wave (Integral P) and the filtered P-wave late potential durations below 3 æV (PL<3). RESULTS: The parameters that presented significant statistical differences between the groups were: FPD, RMS 40, 30 and 20, PL<3, P on ECG and LAD. The ROC curve calculations demonstrated the best cut-off points and performance estimates for each parameter: sensitivity, specificity, area under the curve and p-value (p). CONCLUSION: The time domain P-SAECG proved to be a superior method to identify patients with paroxysmal atrial fibrillation than the conventional electrocardiogram and echocardiogram.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Fibrilação Atrial/diagnóstico , Função Atrial/fisiologia , Eletrocardiografia/métodos , Fibrilação Atrial/fisiopatologia , Curva ROC , Sensibilidade e Especificidade , Processamento de Sinais Assistido por ComputadorRESUMO
OBJECTIVE: To evaluate the frequency, clinical correlations and prognosis influence of late potentials on the of heart failure patients with different etiologies using the signal averaged electrocardiogram. METHODS: A 42 month study of the signal averaged electrocardiograms of 288 heart failure patients with different etiologies was conducted. The group of patients included 215 males (74.65%) and 73 females (25.35%) between the ages of 16 and 70 (mean 51.5, standard deviation 11.24). The heart failure etiologies were: hypertensive heart disease (78 patients, 27.1%); idiopathic dilated cardiomyopathy (73 patients, 25.4%); ischemic cardiomyopathy (65 patients, 22.6%); Chagas disease (42 patients, 14.6%); alcoholic cardiomyopathy (9 patients, 3.1%); peripartum cardiomyopathy (6 patients, 2.1%); valvular heart disease (2 patients, 4.2%) and viral myocarditis (3 patients, 1.04%). The variables included the duration of the standard QRS complex, duration of the filtered QRS complex, duration of the signal below 40 microV and the root mean square of the last 40 ms which were analyzed in regard to age, gender, etiology and mortality as well as the findings of the 12-lead electrocardiogram at rest, echocardiogram and ambulatory electrocardiogram. The statistical analysis tests used were: the Fisher exact probability test, Students t-test, Mann Whitney test, variance analysis, Log-Hank and the Kaplan-Meyer method. RESULTS: Late potentials were diagnosed in 90 patients (31.3%) and there was no association with the etiologies. The presence of this condition is associated with: a lower maximum oxygen uptake during the ergospirometry (p=0.001); sustained and non-sustained ventricular tachycardia during Holter monitoring (p=0.001), sudden death and mortality (p<0.05). Patients that did not present late potentials had a higher overlife rate. CONCLUSION: The presence of late potentials was not associated with the etiologies and proved to be an indication of a worse prognosis.
Assuntos
Eletrocardiografia/métodos , Insuficiência Cardíaca/fisiopatologia , Adolescente , Adulto , Idoso , Causas de Morte , Estudos de Coortes , Morte Súbita Cardíaca , Ecocardiografia , Feminino , Seguimentos , Insuficiência Cardíaca/etiologia , Insuficiência Cardíaca/mortalidade , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , EspirometriaRESUMO
OBJETIVO: Avaliar freqüência, correlações clínicas e influência prognóstica do potencial tardio no eletrocardiograma de alta resolução, em portadores de insuficiência cardíaca de diferentes etiologias. MÉTODOS: Foi estudado o eletrocardiograma de alta resolução, durante 42 meses, em 288 portadores de insuficiência cardíaca de diferentes etiologias, 215 homens (74,65 por cento) e 73 mulheres (25,35), de idades entre 16 e 70 anos (média 51,5, desvio-padrão 11,24). As etiologias da insuficiência cardíaca foram: cardiomiopatia hipertensiva, 78(27,1 por cento); cardiomiopatia dilatada idiopática, 73(25,4 por cento); cardiomiopatia isquêmica, 65(22,6 por cento); cardiomiopatia da doença de Chagas, 42(14,6 por cento); cardiomiopatia alcoólica, 9(3,1 por cento); cardiomiopatia periparto, 6(2,1 por cento); valvopatias em 2(4,2 por cento) e miocardite viral, 3(1,04 por cento). Foram avaliadas a duração do QRS Standard, duração do QRS filtrado, duração do sinal abaixo de 40æV e a raiz quadrada nos últimos 40ms quanto a idade, sexo, etiologia, achados do eletrocardiograma de repouso de 12 derivações, do ecocardiograma, do eletrocardiograma de longa duração e mortalidade. Para a análise estatística, foram utilizados os testes: exato de Fisher, t de Student, de Man-Whitney, análise de variância, Log-HanK e o método de Kaplan-Meyer. RESULTADOS: O potencial tardio foi diagnosticado em 90 (31,3 por cento) pacientes e não houve correlação com as etiologias. Sua presença associou-se a: menor consumo máximo de oxigênio a cicloergoespirometria (p=0,001); taquicardia ventricular sustentada e não sustentada ao Holter (p=0,001), morte súbita e mortalidade (p<0,05). Houve uma maior sobrevida nos pacientes sem potencial tardio. CONCLUSÃO: A presença de potencial tardio não se associou às etiologias e mostrou-se um marcador de pior prognóstico.
OBJECTIVE: To evaluate the frequency, clinical correlations and prognosis influence of late potentials on the of heart failure patients with different etiologies using the signal averaged electrocardiogram. METHODS: A 42 month study of the signal averaged electrocardiograms of 288 heart failure patients with different etiologies was conducted. The group of patients included 215 males (74.65 percent) and 73 females (25.35 percent) between the ages of 16 and 70 (mean 51.5, standard deviation 11.24). The heart failure etiologies were: hypertensive heart disease (78 patients, 27.1 percent); idiopathic dilated cardiomyopathy (73 patients, 25.4 percent); ischemic cardiomyopathy (65 patients, 22.6 percent); Chagas disease (42 patients, 14.6 percent); alcoholic cardiomyopathy (9 patients, 3.1 percent); peripartum cardiomyopathy (6 patients, 2.1 percent); valvular heart disease (2 patients, 4.2 percent) and viral myocarditis (3 patients, 1.04 percent). The variables included the duration of the standard QRS complex, duration of the filtered QRS complex, duration of the signal below 40µV and the root mean square of the last 40ms which were analyzed in regard to age, gender, etiology and mortality as well as the findings of the 12-lead electrocardiogram at rest, echocardiogram and ambulatory electrocardiogram. The statistical analysis tests used were: the Fisher exact probability test, Students t-test, Mann Whitney test, variance analysis, Log-Hank and the Kaplan-Meyer method. RESULTS: Late potentials were diagnosed in 90 patients (31.3 percent) and there was no association with the etiologies. The presence of this condition is associated with: a lower maximum oxygen uptake during the ergospirometry (p=0.001); sustained and non-sustained ventricular tachycardia during Holter monitoring (p=0.001), sudden death and mortality (p<0.05). Patients that did not present late potentials had a higher overlife rate. CONCLUSION: The presence of late potentials was not associated with the etiologies and proved to be an indication of a worse prognosis.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Eletrocardiografia , Insuficiência Cardíaca , Causas de Morte , Estudos de Coortes , Morte Súbita Cardíaca , Ecocardiografia , Seguimentos , Insuficiência Cardíaca , Prognóstico , EspirometriaRESUMO
OBJECTIVE: To analyze the parameters of the time domain P-wave signal-averaged electrocardiogram (P-SAECG) and compare them with the P-wave duration on the conventional electrocardiogram (P on ECG) as well as the left atrium diameter (LAD) and left ventricular ejection fraction (EF) obtained on the echocardiogram in order to evaluate patients with paroxysmal atrial fibrillation (PAF). METHODS: One hundred and eighty-one patients were included in the study: 117 with confirmed PAF and 64 without PAF. The P-SAECG parameters used were: the filtered P-wave duration (FPD), the root mean square (RMS) voltages in the last 40, 30 and 20 ms of the filtered P-wave (RMS 40, RMS 30 and RMS 20), the root mean square voltage of the filtered P-wave potentials (RMS P), the integral of the potentials during the filtered P-wave (Integral P) and the filtered P-wave late potential durations below 3 microV (PL<3). RESULTS: The parameters that presented significant statistical differences between the groups were: FPD, RMS 40, 30 and 20, PL<3, P on ECG and LAD. The ROC curve calculations demonstrated the best cut-off points and performance estimates for each parameter: sensitivity, specificity, area under the curve and p-value (p). CONCLUSION: The time domain P-SAECG proved to be a superior method to identify patients with paroxysmal atrial fibrillation than the conventional electrocardiogram and echocardiogram.
Assuntos
Fibrilação Atrial/diagnóstico , Função Atrial/fisiologia , Eletrocardiografia/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Fibrilação Atrial/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Curva ROC , Sensibilidade e Especificidade , Processamento de Sinais Assistido por ComputadorRESUMO
We present an unusual case of a young Thai immigrant, symptomatic, who had suffered prior episodes of syncope with strong family background: male, first-degree relatives, younger than 45 years old who had died suddenly. The rest ECG, with the patient asymptomatic at the time, showed persistent ST-segment elevation, in inferior leads and "mirror" image in the anterior wall, which were not modified with sublingual nitrates, in absence of demonstrable structural heart disease by chest X-rays and echocardiogram, hypothermia, ischemia, or electrolytic disorders. Holter monitoring revealed at dawn, a short episode of polymorphic ventricular tachycardia of short onset extrasystole coupling, which evolved into asystole and sudden cardiac death. We believe this is a sudden unexplained death syndrome, although we did not have a chance to conduct a genetic study.